In vitro affinity maturation to improve the efficacy of a hypoxia-inducible factor 1α single-domain intrabodyMin Hu, He Huang, Xin Cheng et al.|Biochemical and Biophysical Research Communications|2020Cited by 19
VHH212 nanobody targeting the hypoxia-inducible factor 1α suppresses angiogenesis and potentiates gemcitabine therapy in pancreatic cancer <i>in vivo</i>Guangbo Kang, He Huang, Jiewen Wang et al.|Cancer Biology and Medicine|2021Cited by 19